Jianmin Duan

Jianmin worked for 21 years in drug discovery and development at Boehringer Ingelheim, overseeing all preclinical drug development programs of the company. As an experienced team leader with more than 20 years of track records in drug absorption, distribution, metabolism, excretion, pharmacokinetics and pharmacology, his skills cover three main areas of expertise:

-General and project-specific strategy planning and prioritization: identifying the critical PK/PD parameters for effective optimizations;

-Experimental design, data analysis, and interpretations on ADME/PK and pharmacology studies: ensuring the most efficient use of resources to achieve the highest quality data within the best timeline, such as best dosage selections, sample time, and statistical power.

– Identification of key issues and providing solutions on how to improve oral bioavailability, half-life, IVIVC and human PK/PD/Tox predictions, efficient selection and implementation of PK and PK/PD models, and the application of software to guide drug evolution, candidate selection, toxicology evaluations and clinical trials, as well as staff training.